ArticleAmerican journal of translational research2026

Efficacy and safety of pyrotinib combined with trastuzumab and chemotherapy in patients with HER2-positive locally advanced breast cancer: a multicenter real-world study.

Yujia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.